Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Pinder

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Clinical Radiology|September 29, 2004
Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinomaL J Hamilton, A J Evans, A R M Wilson, et al.
British Journal of Cancer|March 29, 2000
c-erbB-4 protein expression in human breast cancerT Y Kew, J A Bell, S E Pinder, et al.
British Journal of Cancer|January 1, 1995
Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survivalS E Pinder, P Wencyk, D M Sibbering, et al.
Clinical Radiology|August 26, 1998
The accuracy of breast ultrasound in the evaluation of clinically benign discrete, symptomatic breast lumpsD Lister, A J Evans, H C Burrell, et al.
Anticancer Research|March 1, 1996
The significance of p53 autoantibodies in the serum of patients with breast cancerP C Willsher, S E Pinder, L Robertson, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2001
Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison studyR D Macmillan, D Barbera, D J Hadjiminas, et al.
The Journal of Pathology|March 14, 2003
Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centresM Dowsett, J Bartlett, I O Ellis, et al.
Journal of Clinical Pathology|June 22, 2011
HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methodsJ M S Bartlett, J Starczynski, Neil Atkey, et al.
British Journal of Cancer|February 22, 2017
Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trialS E Pinder, A F Campbell, J M S Bartlett, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2014
Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationshipA Purushotham, E Shamil, M Cariati, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Clinical Radiology|September 29, 2004
Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinomaL J Hamilton, A J Evans, A R M Wilson, et al.
British Journal of Cancer|March 29, 2000
c-erbB-4 protein expression in human breast cancerT Y Kew, J A Bell, S E Pinder, et al.
British Journal of Cancer|January 1, 1995
Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survivalS E Pinder, P Wencyk, D M Sibbering, et al.
Clinical Radiology|August 26, 1998
The accuracy of breast ultrasound in the evaluation of clinically benign discrete, symptomatic breast lumpsD Lister, A J Evans, H C Burrell, et al.
Anticancer Research|March 1, 1996
The significance of p53 autoantibodies in the serum of patients with breast cancerP C Willsher, S E Pinder, L Robertson, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2001
Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison studyR D Macmillan, D Barbera, D J Hadjiminas, et al.
The Journal of Pathology|March 14, 2003
Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centresM Dowsett, J Bartlett, I O Ellis, et al.
Journal of Clinical Pathology|June 22, 2011
HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methodsJ M S Bartlett, J Starczynski, Neil Atkey, et al.
British Journal of Cancer|February 22, 2017
Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trialS E Pinder, A F Campbell, J M S Bartlett, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2014
Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationshipA Purushotham, E Shamil, M Cariati, et al.
Pageof 15